144 GPR133 Promotes Glioblastoma Growth in Hypoxia
نویسندگان
چکیده
منابع مشابه
Nodal Promotes Glioblastoma Cell Growth
Nodal is a member of the transforming growth factor-β (TGF-β) superfamily that plays critical roles during embryogenesis. Recent studies in ovarian, breast, prostate, and skin cancer cells suggest that Nodal also regulates cell proliferation, apoptosis, and invasion in cancer cells. However, it appears to exert both tumor-suppressing and tumor-promoting effects, depending on the cell type. To f...
متن کاملHypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
Despite the impressive progress over the past decade, in the field of tumor immunology, such as the identification of tumor antigens and antigenic peptides, there are still many obstacles in eliciting an effective immune response to eradicate cancer. It has become increasingly clear that tumor microenvironment plays a crucial role in the control of immune protection. Tumors have evolved to util...
متن کاملHypoxia and glioblastoma therapy
is the most common primary malignancy in adults. Despite improvements in chemoradiotherapeutic strategies, patients typically survive for less than one year [1]. Bevacizumab (BVZ), a humanized monoclonal antibody against vascular epithelial growth factor (vegf), alters the kinetics of ligand binding and has been shown to abrogate angiogenesis in different types of solid tumors [2]. The initial ...
متن کاملHDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation
Histone deacetylase 9 (HDAC9), a member of class II HDACs, regulates a wide variety of normal and abnormal physiological functions. We found that HDAC9 is over-expressed in prognostically poor glioblastoma patients. Knockdown HDAC9 decreased proliferation in vitro and tumor formation in vivo. HDAC9 accelerated cell cycle in part by potentiating the EGFR signaling pathway. Also, HDAC9 interacted...
متن کاملHypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.
Antiangiogenic therapy leads to devascularization that limits tumor growth. However, the benefits of angiogenesis inhibitors are typically transient and resistance often develops. In this study, we explored the hypothesis that hypoxia caused by antiangiogenic therapy induces tumor cell autophagy as a cytoprotective adaptive response, thereby promoting treatment resistance. Hypoxia-induced autop...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurosurgery
سال: 2016
ISSN: 0148-396X
DOI: 10.1227/01.neu.0000489714.29455.e6